CRBs are still in a holding pattern when it comes to any new developments for traditional banking and lending access. However, there are more banks than ever doing business with the industry and political shifts in Washington offer a hopeful outlook for future legislative changes.
Probably not, but we’re getting close. In this piece, Johnson discusses some upcoming legislation that could be key in the path towards federal legalization in the United States.
New market opportunities, more requirements in testing regulations, new technologies and other factors are leading to a much larger cannabis testing market in the next five years.
In this op-ed, Johnson suggests cannabis industry infighting and stakeholders more concerned with profits over public health only hurts the greater cause. He thinks prohibition should be the enemy, not Delta 8.
On the road to nationwide legalization, cannabis and spirits share similar stories. But here’s the one step the cannabis industry should avoid copying, if it can.
It can be challenging to translate highly technical test results into consumer-friendly language but being able to do so will enable businesses to build a stronger relationship with customers. Rely on your trusted lab partners to help design and deliver easy to understand, consumer friendly certificates of analysis.
When things go wrong in our imperfect business and world, how do you address them? A CAPA program can help businesses identify problems, their causes and offer solutions for preventing future problems.
New product developments, regional demand shifts and different drug delivery mechanisms will become more disruptive for the global medical cannabis market in the years to come.
On August 25, cannabis labs and those interested in learning more about cannabis lab testing should take advantage of this complimentary event.
During a press conference held on July 14, Senate Majority Leader Chuck Schumer, Senate Finance Committee Chair Ron Wyden and Senator Cory Booker introduced the Cannabis Administration And Opportunity Act, a bill that would remove cannabis from the list of controlled substances. This is the first time that a Senate Majority Leader has introduced such a bill.
